News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Horobin Joanna
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 01/19/2023 |
4
| Horobin Joanna (Director) has filed a Form 4 on Vyant Bio, Inc.|
Txns:
| Granted 7,526 shares
@ $0 |
|
| 10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Horobin Joanna (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 12,000 options to buy
@ $14.18, valued at
$170.2k
|
|
| 04/19/2022 |
4
| Horobin Joanna (Director) has filed a Form 4 on Vyant Bio, Inc.|
Txns:
| Granted 6,796 shares
@ $0 |
|
| 04/01/2022 |
4
| Horobin Joanna (Director) has filed a Form 4 on Vyant Bio, Inc.|
Txns:
| Granted 43,478 shares
@ $0 |
|
| 01/20/2022 |
4
| Horobin Joanna (Director) has filed a Form 4 on Vyant Bio, Inc.|
Txns:
| Granted 5,343 shares
@ $1.31, valued at
$7k
|
|
| 09/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/21/2020 |
4
| Horobin Joanna (Director) has filed a Form 4 on Kymera Therapeutics, Inc.|
Txns:
| Granted 40,127 options to buy
@ $20, valued at
$802.5k
|
|
| 06/23/2020 |
4
| Horobin Joanna (Director) has filed a Form 4 on Liquidia Technologies Inc|
Txns:
| Granted 20,000 options to buy
@ $10.97, valued at
$219.4k
|
|
| 09/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2019 |
4
| Horobin Joanna (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 45,500 options to buy
@ $2.52, valued at
$114.7k
|
|
| 01/07/2019 |
4
| Horobin Joanna (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 18,100 shares
@ $0
Granted 45,500 options to buy
@ $3.14, valued at
$142.9k
|
|
| 12/20/2018 |
4
| Horobin Joanna (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Bought 300 shares
@ $3.45, valued at
$1k
|
|
| 08/15/2018 |
4
| Horobin Joanna (Chief Medical Officer) has filed a Form 4 on IDERA PHARMACEUTICALS, INC.|
Txns:
| Granted 32,500 options
@ $7.39, valued at
$240.2k
|
|
| 01/05/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|